Receptor Activator of NF-κB Ligand Promotes the Production of CCL17 from RANK+ M2 Macrophages.
about
RANK-RANKL signalling in cancerSuccessful Treatment of Advanced Primary Cutaneous Apocrine Carcinoma on the Scrotum with Systemic Chemotherapy and Radiotherapy Followed by Denosumab.RANK as a therapeutic target in cancer.Merkel Cell Carcinoma with Spontaneous Regression: A Case Report and Immunohistochemical Study.RANKL-Expressing Ectopic Extramammary Paget's Disease on the Lower Abdomen.Periostin in the Cancer Stroma of Mycosis Fungoides Palmaris et Plantaris: A Case Report and Immunohistochemical Study.A possible interaction between periostin and CD163+ skin-resident macrophages in pemphigus vulgaris and bullous pemphigoid.Cytotoxic antimelanoma drugs suppress the activation of M2 macrophages.Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer.Possible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget disease by receptor activator of nuclear factor kappa B (RANK) ligand/RANK pathways.RANKL expression is a useful marker for differentiation of pagetoid squamous cell carcinoma in situ from extramammary Paget disease.Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study.
P2860
Q26747442-3C7EDDF6-B240-4C1C-A204-FC902C326BFAQ37634857-5436DCEC-DC46-4BB1-A9FC-B5FC1B9C8CE8Q38691526-76055B0E-F0C2-4080-9650-726055C8EE76Q41851924-07DEB39E-1B03-424B-B51E-84790BA41337Q41908586-24566EB9-32D4-4BD3-8E4D-8E9958878380Q42091220-CE8E1C47-A688-4C59-9E44-531C98661724Q47862439-53402615-33D8-4320-A341-0419F8AC606DQ47916295-67FB9EDD-2671-44C7-BFC7-596D8676A5A7Q49168232-3CCDDFA5-4EAD-4B78-97A2-D66EB03F5A20Q51644067-43CD6A42-61C7-4A59-9866-2DE85B62899DQ51725474-E88F84EE-9991-4A5D-91CB-FE035B829A17Q52674779-353F8FCE-E289-44F3-9662-379C5DC5F00DQ55004957-853B2EEE-AC29-4C87-9CD0-640A53C99B73
P2860
Receptor Activator of NF-κB Ligand Promotes the Production of CCL17 from RANK+ M2 Macrophages.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Receptor Activator of NF-κB Li ...... L17 from RANK+ M2 Macrophages.
@en
Receptor Activator of NF-κB Li ...... L17 from RANK+ M2 Macrophages.
@nl
type
label
Receptor Activator of NF-κB Li ...... L17 from RANK+ M2 Macrophages.
@en
Receptor Activator of NF-κB Li ...... L17 from RANK+ M2 Macrophages.
@nl
prefLabel
Receptor Activator of NF-κB Li ...... L17 from RANK+ M2 Macrophages.
@en
Receptor Activator of NF-κB Li ...... L17 from RANK+ M2 Macrophages.
@nl
P2093
P356
P1476
Receptor Activator of NF-κB Li ...... L17 from RANK+ M2 Macrophages.
@en
P2093
Aya Kakizaki
Masayuki Asano
Sadanori Furudate
Setsuya Aiba
Taku Fujimura
Yumi Kambayashi
P2888
P304
P356
10.1038/JID.2015.209
P407
P577
2015-06-08T00:00:00Z